Rankings
▼
Calendar
SLDB FY 2016 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena
SLDB
Solid Biosciences Inc.
$581M
FY 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$56,000
Operating Income
-$26M
Net Income
-$22M
EPS (Diluted)
$-16.80
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$21M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$41M
Total Liabilities
$79M
Stockholders' Equity
-$84M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$56,000
$0
—
Operating Income
-$26M
-$7M
-289.6%
Net Income
-$22M
-$6M
-237.8%
← FY 2015
All Quarters
Q1 2016 →